Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innogenix is a specialty pharmaceutical company based in Somerset, New Jersey, that focuses on the development, manufacturing, and commercialization of generic prescription drugs. The company specializes in complex dosage forms, particularly oral liquids and solids, and maintains a robust pipeline of Abbreviated New Drug Applications (ANDAs). With a state-of-the-art FDA-approved manufacturing facility, Innogenix integrates R&D with commercial-scale production to ensure high-quality and affordable healthcare solutions. Their portfolio includes treatments for pain management, cardiovascular conditions, and other therapeutic areas. Innogenix also leverages its technical expertise to provide contract development and manufacturing services to the broader pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innogenix.